Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Babcock & Wilcox Enterprises Inc (BW)
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-11-04
$3.10-15.99%
Close 2026-11-05 · 1-day change
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.43 → 0.43 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BW yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve $80M-$100M Adjusted EBITDA in 2026 | Babcock & Wilcox aims for $80M-$100M adjusted EBITDA in 2026. | Improving | Adjusted EBITDA falls below $80M in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “In addition, we have raised the upper end of our 2026 Adjusted EBITDA target range to $80.0 million to $105.0 million, reflecting the continued momentum across our business and confidence in additional opportunities ahead.” “Adjusted EBITDA was $21.8 million, an increase compared to $13.9 million in the second quarter of 2025.” Revenue was $319.716 million in 2026-Q2. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk turnaround and growth story, not yet a proven durable compounder. The thesis is on watch: adjusted EBITDA has improved and guidance was raised, but recent financial performance remains below its industry cohort and earnings quality is still loss-making.
The valuation evidence points to BW as cheap versus peers, while the expectations gap is negative, suggesting expectations are cautious. The model’s confidence is medium, and valuation rose recently, so the relative discount alone does not establish that execution risks are resolved.
Near term, the main test is whether management delivers its 2026 adjusted EBITDA target of $80 million to $105 million after raising the upper end of its range. Adjusted EBITDA increased from $13.9 million in 2025-Q2 to $21.8 million in 2026-Q2, and management reports progress on data-center power projects. Earnings surprises have been erratic, and a guidance cut after a recent increase would further damage management credibility.
The multi-year view depends on continued progress toward the earnings target and execution on the Siemens Energy turbine supply and Base Electron data-center project. Sector conditions are another swing factor: continued strength from industrial bellwethers could support the backdrop, while misses or lower guidance from those companies could remove that support. The share repurchase program is authorized, but no repurchases have yet been reported.
Over the next one to three years, BW’s case depends on turning improved adjusted EBITDA and active project execution into sustained financial progress; the current evidence remains mixed, with high risk and a medium level of confidence. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain strong capital position after $230M stock offering | The company strengthened its capital with a $230M stock offering. | Intact | Capital position weakens or requires dilutive financing | Capital position stable; $50M buyback authorized, no dilutive financing BW authorized $50M buyback, redeemed 6.50% notes, and beat Q2 earnings, confirming strong capital position. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Manage and resolve class action legal risks | A supporting condition in Babcock & Wilcox Enterprises Inc's published investment case. The stated target is No material adverse legal rulings or settlements. | Intact | Material negative legal rulings or settlements announced | 0 material legal rulings vs 0 target News and events focus on earnings beats, buybacks, and turbine deals; no legal issues reported. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain strong revenue growth supporting EBITDA target | A primary condition in Babcock & Wilcox Enterprises Inc's published investment case. The stated target is >=50% YoY. | Intact | Revenue growth falls below 30% YoY in FY26 | Revenue growth: 121.94% FY2026-Q2; GAAP. Published target: >=50% YoY. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 2026121.941772 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “In addition, we have raised the upper end of our 2026 Adjusted EBITDA target range to $80.0 million to $105.0 million, reflecting the continued momentum across our business and confidence in additional opportunities ahead.” “Adjusted EBITDA was $21.8 million, an increase compared to $13.9 million in the second quarter of 2025.” Revenue was $319.716 million in 2026-Q2. Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.44 → $0.43 · observed estimates
$1.21B → $1.28B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-07-25 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-07-26 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-07-27 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-07-28 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-07-29 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-07-30 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-07-31 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-01 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-02 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-03 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-04 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-05 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-06 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-07 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-08 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-09 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-10 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-11 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-12 | $0.47 | $1,213,766,670 | 2 / 3 |
| 2026-08-13 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-14 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-15 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-16 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-17 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-18 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-19 | $0.44 | $1,213,717,467 | 2 / 2 |
| 2026-08-20 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-21 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-22 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-23 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-24 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-25 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-26 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-27 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-28 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-29 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-30 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-08-31 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-09-01 | $0.44 | $1,222,433,333 | 2 / 2 |
| 2026-09-02 | $0.43 | $1,282,100,000 | 2 / 2 |
| 2026-09-03 | $0.43 | $1,282,100,000 | 2 / 2 |
| 2026-09-04 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-05 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-06 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-07 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-08 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-09 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-10 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-11 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-12 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-13 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-14 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-15 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-16 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-17 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-18 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-19 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-20 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-21 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-22 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-23 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-24 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-25 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-26 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-27 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-28 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-29 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-09-30 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-01 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-02 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-03 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-04 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-05 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-06 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-07 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-08 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-09 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-10 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-11 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-12 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-13 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-14 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-15 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-16 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-17 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-18 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-19 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-20 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-21 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-22 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-23 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-24 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-25 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-26 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-27 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-28 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-29 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-30 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-10-31 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-11-01 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-11-02 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-11-03 | $0.43 | $1,282,100,000 | 3 / 3 |
| 2026-11-04 | $0.43 | $1,282,100,000 | 3 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.